Switzerland-based Carbogen Amcis, a pharmaceutical process development and API manufacturing company, announced that Mark C. Griffiths has been named chief executive officer, effective immediately. In his new role, Griffiths will have responsibility for the company's Swiss business and will report to Jay Vyas, managing director of Dishman Pharmaceuticals and Chemicals, Carbogen Amcis' parent company.

Griffiths has been associated with Carbogen Amcis as director of operations and chief executive officer for almost 10 years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group's large-scale manufacturing facilities for commercial supply of highly potent APIs (HPAPIs) in Shanghai, China, and Ahmedabad, India.